JP2018505158A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2018505158A5 JP2018505158A5 JP2017536879A JP2017536879A JP2018505158A5 JP 2018505158 A5 JP2018505158 A5 JP 2018505158A5 JP 2017536879 A JP2017536879 A JP 2017536879A JP 2017536879 A JP2017536879 A JP 2017536879A JP 2018505158 A5 JP2018505158 A5 JP 2018505158A5
- Authority
- JP
- Japan
- Prior art keywords
- pharmaceutical composition
- odd
- chain fatty
- fatty acids
- composition according
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000008194 pharmaceutical composition Substances 0.000 claims 20
- 235000014113 dietary fatty acids Nutrition 0.000 claims 13
- 229930195729 fatty acid Natural products 0.000 claims 13
- 239000000194 fatty acid Substances 0.000 claims 13
- 150000004665 fatty acids Chemical class 0.000 claims 13
- 210000002966 serum Anatomy 0.000 claims 8
- 208000001145 Metabolic Syndrome Diseases 0.000 claims 5
- 201000000690 abdominal obesity-metabolic syndrome Diseases 0.000 claims 5
- 102000008857 Ferritin Human genes 0.000 claims 3
- 108050000784 Ferritin Proteins 0.000 claims 3
- 238000008416 Ferritin Methods 0.000 claims 3
- 210000003617 erythrocyte membrane Anatomy 0.000 claims 3
- 150000003839 salts Chemical class 0.000 claims 3
- 238000011282 treatment Methods 0.000 claims 3
- 102100032752 C-reactive protein Human genes 0.000 claims 2
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 claims 2
- 102000015779 HDL Lipoproteins Human genes 0.000 claims 2
- 108010010234 HDL Lipoproteins Proteins 0.000 claims 2
- 208000028958 Hyperferritinemia Diseases 0.000 claims 2
- 208000031226 Hyperlipidaemia Diseases 0.000 claims 2
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 claims 2
- 206010065973 Iron Overload Diseases 0.000 claims 2
- 230000036772 blood pressure Effects 0.000 claims 2
- 230000037396 body weight Effects 0.000 claims 2
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 claims 2
- 239000008103 glucose Substances 0.000 claims 2
- KEMQGTRYUADPNZ-UHFFFAOYSA-N heptadecanoic acid Chemical compound CCCCCCCCCCCCCCCCC(O)=O KEMQGTRYUADPNZ-UHFFFAOYSA-N 0.000 claims 2
- 230000002265 prevention Effects 0.000 claims 2
- 150000003626 triacylglycerols Chemical class 0.000 claims 2
- 208000004611 Abdominal Obesity Diseases 0.000 claims 1
- 108010076365 Adiponectin Proteins 0.000 claims 1
- 102000011690 Adiponectin Human genes 0.000 claims 1
- 101710155857 C-C motif chemokine 2 Proteins 0.000 claims 1
- 108010074051 C-Reactive Protein Proteins 0.000 claims 1
- 208000024172 Cardiovascular disease Diseases 0.000 claims 1
- 206010065941 Central obesity Diseases 0.000 claims 1
- 102000000018 Chemokine CCL2 Human genes 0.000 claims 1
- 208000004930 Fatty Liver Diseases 0.000 claims 1
- 206010019708 Hepatic steatosis Diseases 0.000 claims 1
- 102000004889 Interleukin-6 Human genes 0.000 claims 1
- 108090001005 Interleukin-6 Proteins 0.000 claims 1
- 108010055717 JNK Mitogen-Activated Protein Kinases Proteins 0.000 claims 1
- 206010028980 Neoplasm Diseases 0.000 claims 1
- 108060008682 Tumor Necrosis Factor Proteins 0.000 claims 1
- 102000000852 Tumor Necrosis Factor-alpha Human genes 0.000 claims 1
- 208000006673 asthma Diseases 0.000 claims 1
- 108091006374 cAMP receptor proteins Proteins 0.000 claims 1
- 201000011510 cancer Diseases 0.000 claims 1
- 201000001883 cholelithiasis Diseases 0.000 claims 1
- 235000012000 cholesterol Nutrition 0.000 claims 1
- 206010012601 diabetes mellitus Diseases 0.000 claims 1
- 239000002552 dosage form Substances 0.000 claims 1
- 239000003937 drug carrier Substances 0.000 claims 1
- 208000010706 fatty liver disease Diseases 0.000 claims 1
- 229910052742 iron Inorganic materials 0.000 claims 1
- 239000003550 marker Substances 0.000 claims 1
- 239000000203 mixture Substances 0.000 claims 1
- 201000010065 polycystic ovary syndrome Diseases 0.000 claims 1
- 238000002203 pretreatment Methods 0.000 claims 1
- 230000000770 proinflammatory effect Effects 0.000 claims 1
- 238000011321 prophylaxis Methods 0.000 claims 1
- 230000003331 prothrombotic effect Effects 0.000 claims 1
- 150000004671 saturated fatty acids Chemical class 0.000 claims 1
- 235000003441 saturated fatty acids Nutrition 0.000 claims 1
- 208000019116 sleep disease Diseases 0.000 claims 1
- 231100000240 steatosis hepatitis Toxicity 0.000 claims 1
- 208000024891 symptom Diseases 0.000 claims 1
- 208000001072 type 2 diabetes mellitus Diseases 0.000 claims 1
- 230000002485 urinary effect Effects 0.000 claims 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US14/591,660 US9561206B2 (en) | 2015-01-07 | 2015-01-07 | Use of heptadecanoic acid (C17:0) to detect risk of and treat hyperferritinemia and metabolic syndrome |
| US14/591,660 | 2015-01-07 | ||
| PCT/US2015/067172 WO2016111843A1 (en) | 2015-01-07 | 2015-12-21 | Compositions and methods for diagnosis and treatment of metabolic syndrome |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020002588A Division JP2020055875A (ja) | 2015-01-07 | 2020-01-10 | 代謝症候群の診断および処置のための組成物および方法 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2018505158A JP2018505158A (ja) | 2018-02-22 |
| JP2018505158A5 true JP2018505158A5 (https=) | 2019-01-24 |
| JP7064879B2 JP7064879B2 (ja) | 2022-05-11 |
Family
ID=55085946
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2017536879A Active JP7064879B2 (ja) | 2015-01-07 | 2015-12-21 | 代謝症候群の診断および処置のための組成物および方法 |
| JP2020002588A Pending JP2020055875A (ja) | 2015-01-07 | 2020-01-10 | 代謝症候群の診断および処置のための組成物および方法 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020002588A Pending JP2020055875A (ja) | 2015-01-07 | 2020-01-10 | 代謝症候群の診断および処置のための組成物および方法 |
Country Status (6)
| Country | Link |
|---|---|
| US (6) | US9561206B2 (https=) |
| EP (2) | EP4410285A3 (https=) |
| JP (2) | JP7064879B2 (https=) |
| AR (1) | AR103371A1 (https=) |
| TW (1) | TW201639557A (https=) |
| WO (1) | WO2016111843A1 (https=) |
Families Citing this family (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US10022347B2 (en) * | 2015-01-07 | 2018-07-17 | The United States Of America, As Represented By The Secretary Of The Navy | Compositions and methods for diagnosis and treatment of metabolic syndrome |
| US9561206B2 (en) * | 2015-01-07 | 2017-02-07 | The United States Of America, As Represented By The Secretary Of The Navy | Use of heptadecanoic acid (C17:0) to detect risk of and treat hyperferritinemia and metabolic syndrome |
| WO2018089773A1 (en) * | 2016-11-10 | 2018-05-17 | Fractyl Laboratories, Inc. | Systems, devices, and methods for performing medical procedures in the intestine |
| US10307388B2 (en) * | 2016-12-29 | 2019-06-04 | The United States Of America As Represented By The Secretary Of The Navy | Compositions and methods for diagnosis and treatment of inflammation |
| US10238618B2 (en) * | 2016-12-29 | 2019-03-26 | The United States Of America As Represented By The Secretary Of The Navy | Compositions and methods for diagnosis and treatment of anemia |
| AU2018354090B2 (en) * | 2017-10-23 | 2024-10-24 | Epitracker, Inc. | Fatty acid analogs and their use in the treatment of conditions related to metabolic syndrome |
| EP3793560A4 (en) * | 2018-05-16 | 2022-03-23 | Epitracker, Inc. | COMPOSITIONS AND METHODS FOR DIAGNOSIS AND TREATMENT OF AGING-RELATED CONDITIONS |
| AU2019274431B2 (en) | 2018-05-23 | 2025-03-13 | Epitracker, Inc. | Compositions and methods for diagnosis and treatment of conditions related to the quality of aging and longevity |
| EP3908374A4 (en) | 2019-01-09 | 2022-12-28 | Epitracker, Inc. | COMPOSITIONS AND METHODS FOR DIAGNOSIS AND TREATMENT OF NEURODEGENERATIVE DISEASES |
| WO2020180814A1 (en) | 2019-03-04 | 2020-09-10 | Epitracker, Inc. | Fatty acid analogs and their use in the treatment of cognitive impairment, behavioral conditions, and chronic pain |
| CN110129400B (zh) * | 2019-05-25 | 2023-09-01 | 华南理工大学 | 一种提高微生物油脂奇数碳链脂肪酸含量的方法 |
| AU2021329343A1 (en) * | 2020-08-20 | 2023-03-09 | Epitracker, Inc. | Compositions and methods for treatment of obesity |
| WO2022220755A1 (en) * | 2021-04-16 | 2022-10-20 | Wilmar International Limited | Triacylglycerol (tag) composition, manufacturing, and uses thereof |
| EP4426130A1 (en) | 2021-11-03 | 2024-09-11 | Epitracker, Inc. | Pentadecanoylcarnitine for treatment of conditions related to the quality of aging and longevity |
| CN115894217B (zh) * | 2022-10-19 | 2025-01-17 | 福建农林大学 | 一种具有降血糖作用的十七烷酸的制备与应用 |
| EP4689669A1 (en) * | 2023-03-31 | 2026-02-11 | Quest Diagnostics Investments LLC | Methods for quantitation of adiponectin by mass spectrometry |
Family Cites Families (34)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE2615061A1 (de) | 1976-04-05 | 1977-10-06 | Wolfgang Dr Med Wagner | Injektionsverfahren und -vorrichtungen |
| US4252159A (en) | 1979-04-02 | 1981-02-24 | Maki Eugene B | Dosage device |
| JPS60172925A (ja) * | 1984-02-17 | 1985-09-06 | Kao Corp | 胆石溶解剤 |
| JPS6115809A (ja) * | 1984-06-29 | 1986-01-23 | Lion Corp | 細胞賦活剤 |
| DE3501534A1 (de) | 1984-09-22 | 1986-05-15 | Walter Ing.(grad.) 7758 Meersburg Holzer | Verfahren und vorrichtung zum dosieren von insulin oder aehnlichen langzeitmedikamenten |
| JPS6212716A (ja) * | 1985-07-11 | 1987-01-21 | Nippon Oil & Fats Co Ltd | 制がん剤 |
| DE3875075D1 (de) | 1987-11-25 | 1992-11-05 | Siemens Ag | Dosiergeraet zum gesteuerten injizieren von fluessigkeiten aus einem vorratsbehaelter in einen organismus. |
| EP0569618B1 (de) | 1992-05-12 | 1997-01-02 | Siemens-Elema AB | Dosiergerät zur gesteuerten Abgabe einer Flüssigkeit |
| JP3558351B2 (ja) * | 1992-12-07 | 2004-08-25 | 邦郎 辻 | 免疫抑制剤 |
| AUPN137895A0 (en) * | 1995-02-27 | 1995-03-16 | Clover Corporation Pty Ltd | Composition and method |
| JP2003160486A (ja) * | 2001-09-17 | 2003-06-03 | Lion Corp | 経口養育毛剤及び該養育毛剤を含有する飲食品 |
| US20030203042A1 (en) * | 2002-04-24 | 2003-10-30 | Cook Lisa Ann | Compositions comprising milk protein concentrate and fatty acid and processes of their preparation |
| US20030203004A1 (en) * | 2002-04-24 | 2003-10-30 | Kelm Gary Robert | Compositions comprising short and long chain fatty acids and methods of their use for the management of body weight |
| WO2005099483A1 (en) | 2004-04-16 | 2005-10-27 | Indevex Ab | Ingestible composition |
| WO2005113036A1 (en) | 2004-05-13 | 2005-12-01 | The Regents Of The University Of California | Method and apparatus for glucose control and insulin dosing for diabetics |
| WO2005120484A1 (ja) * | 2004-06-09 | 2005-12-22 | Kurume University | グレリンの生理学的機能のレギュレーター |
| CA2483675A1 (en) | 2004-10-01 | 2006-04-01 | Jens Peschardt | Food bar |
| US8251904B2 (en) | 2005-06-09 | 2012-08-28 | Roche Diagnostics Operations, Inc. | Device and method for insulin dosing |
| JP2008255022A (ja) * | 2007-04-02 | 2008-10-23 | Kureha Corp | 抗癌性物質 |
| DE102007055636A1 (de) | 2007-11-21 | 2009-05-28 | Robert Bosch Gmbh | Medikamenten-Dosiervorrichtung zum Verabreichen eines flüssigen Medikaments |
| EP2316445A4 (en) * | 2008-06-11 | 2011-12-21 | Ricom Corp | HUMAN BETA3 ADRENERGER RECEPTOR LIGAND AND THEREOF FOOD OR PHARMACEUTICAL PREPARATION |
| JP2010260833A (ja) * | 2009-05-11 | 2010-11-18 | Daicho Kikaku:Kk | 抗自己免疫疾患剤 |
| CA2785714C (en) * | 2009-12-30 | 2016-01-26 | Baylor Research Institute | Anaplerotic therapy for alzheimer's disease and the aging brain |
| US20120072236A1 (en) | 2010-08-06 | 2012-03-22 | Benjamin Atkin | Insulin pen data recording and transmission device |
| GB201020133D0 (en) * | 2010-11-26 | 2011-01-12 | Royal Holloway & Bedford New College | Therapeutic use of compounds |
| CN203915611U (zh) | 2011-02-09 | 2014-11-05 | 贝克顿·迪金森公司 | 与输注基部附接的套节及用于传送药物的传送系统 |
| ITMI20111284A1 (it) * | 2011-07-11 | 2013-01-12 | Giovanni Nusca | Composizione farmaceutica. |
| JP7171190B2 (ja) * | 2014-11-11 | 2022-11-15 | コーニンクレッカ フィリップス エヌ ヴェ | 線源－検出器装置 |
| US9561206B2 (en) * | 2015-01-07 | 2017-02-07 | The United States Of America, As Represented By The Secretary Of The Navy | Use of heptadecanoic acid (C17:0) to detect risk of and treat hyperferritinemia and metabolic syndrome |
| US10022347B2 (en) * | 2015-01-07 | 2018-07-17 | The United States Of America, As Represented By The Secretary Of The Navy | Compositions and methods for diagnosis and treatment of metabolic syndrome |
| US9662306B2 (en) * | 2015-01-07 | 2017-05-30 | The United States Of America, As Represented By The Secretary Of The Navy | Compositions and methods for diagnosis and treatment of metabolic syndrome |
| US10307388B2 (en) * | 2016-12-29 | 2019-06-04 | The United States Of America As Represented By The Secretary Of The Navy | Compositions and methods for diagnosis and treatment of inflammation |
| US10238618B2 (en) * | 2016-12-29 | 2019-03-26 | The United States Of America As Represented By The Secretary Of The Navy | Compositions and methods for diagnosis and treatment of anemia |
| JP7001554B2 (ja) * | 2018-06-27 | 2022-01-19 | ヤンマーパワーテクノロジー株式会社 | クレーン機能付き油圧ショベル |
-
2015
- 2015-01-07 US US14/591,660 patent/US9561206B2/en active Active
- 2015-12-21 EP EP24161769.5A patent/EP4410285A3/en active Pending
- 2015-12-21 JP JP2017536879A patent/JP7064879B2/ja active Active
- 2015-12-21 WO PCT/US2015/067172 patent/WO2016111843A1/en not_active Ceased
- 2015-12-21 EP EP15823481.5A patent/EP3247346B1/en active Active
- 2015-12-28 US US14/981,130 patent/US9713600B2/en active Active
- 2015-12-28 US US14/980,167 patent/US20160195558A1/en not_active Abandoned
- 2015-12-28 US US14/980,304 patent/US9707199B2/en active Active
- 2015-12-28 US US14/980,695 patent/US9687461B2/en active Active
-
2016
- 2016-01-06 AR ARP160100021A patent/AR103371A1/es unknown
- 2016-01-06 TW TW105100321A patent/TW201639557A/zh unknown
-
2019
- 2019-08-07 US US16/534,382 patent/US11116740B2/en active Active
-
2020
- 2020-01-10 JP JP2020002588A patent/JP2020055875A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2018505158A5 (https=) | ||
| Cui et al. | Recent advances in the pharmacological applications and liver toxicity of triptolide | |
| RU2017115772A (ru) | Комбинация для генотерапии | |
| JP2012193216A5 (https=) | ||
| JP2009215293A5 (https=) | ||
| HRP20192291T1 (hr) | Bardoksolon-metil, namijenjen liječenju pretilosti | |
| JP2015517488A5 (https=) | ||
| JP2014528474A5 (https=) | ||
| RU2015134581A (ru) | Доноры нитроксила с улучшенным терапевтическим индексом | |
| AR103371A1 (es) | Composiciones y métodos para diagnosis y tratamiento de síndrome metabólico, uso | |
| JP2015508765A5 (https=) | ||
| JP2016511753A5 (https=) | ||
| JP2020502156A5 (https=) | ||
| JP2017512194A5 (https=) | ||
| JP2015522603A5 (https=) | ||
| JP2017519028A5 (https=) | ||
| JP2017014206A5 (https=) | ||
| JP2011157375A5 (https=) | ||
| JP2013501049A5 (https=) | ||
| CN103239439B (zh) | 用于治疗高血脂及动脉粥样硬化的组合物及其用途 | |
| RU2015127834A (ru) | Способы лечения диабета путем введения антагониста рецептора глюкагона в сочетании с ингибитором поглощения холестерина | |
| JP2015501832A5 (https=) | ||
| RU2011122598A (ru) | Композиции на основе d-тагатозы и способы предупреждения и лечения атеросклероза, метаболического синдрома и их симптомов | |
| CN105777520A (zh) | 一种新型查尔酮化合物Chalcone-1203及其组合物、制备方法和应用 | |
| JP2017508455A5 (https=) |